๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma

โœ Scribed by Amine Masmoudi; Nabil Toumi; Afef Khanfir; Lamia Kallel-Slimi; Jamel Daoud; Hela Karray; Mounir Frikha

Book ID
116395131
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
164 KB
Volume
33
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Epstein-Barr virus and nasopharyngeal ca
Epstein-Barr virus and nasopharyngeal carcinoma
โœ Dr. Gary R. Pearson ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 411 KB

The Epstein-Barr virus (EBV) has been studied for over 25 years as a probable cause of certain human cancers, including nasopharyngeal carcinoma (NPC). This is a low-incidence head and neck cancer in Western countries (including the USA), but is the third-leading cancer in males in Southeast Asia. E

Epstein-Barr virus expression within ker
Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma
โœ Zhang, J. X.; Chen, H. L.; Zong, Y. S.; Chan, K. H.; Nicholls, J.; Middeldorp, J ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 730 KB

Three stages of maturation can be seen in keratinizing nasopharyngeal carcinomas. These stages are similar morphologically to basal cells, intermediate and superficial squamous cells seen in normal squamous epithelium. Taking advantage of such a diverse tumour cell population, 10 keratinizing nasoph